BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1020 related articles for article (PubMed ID: 17700157)

  • 21. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression.
    Toniutto P; Minisini R; Fabris C; De Feo T; Marangoni F; Burlone M; Avellini C; Bitetto D; Fornasiere E; Fumolo E; Baccarani U; Pirisi M
    Clin Transplant; 2009; 23(2):184-90. PubMed ID: 19210526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P
    Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.
    Berenguer M; Prieto M; San Juan F; Rayón JM; Martinez F; Carrasco D; Moya A; Orbis F; Mir J; Berenguer J
    Hepatology; 2002 Jul; 36(1):202-10. PubMed ID: 12085366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of marginal donors to liver transplantation for hepatitis C virus infection.
    Briceño J; Ciria R; Pleguezuelo M; Naranjo A; Sánchez-Hidalgo J; Ruiz-Rabelo J; López-Cillero P; Luque A; de la Mata M; Rufián S
    Transplant Proc; 2007 Sep; 39(7):2297-9. PubMed ID: 17889169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant.
    Ward SC; Schiano TD; Thung SN; Fiel MI
    Liver Transpl; 2009 Dec; 15(12):1826-33. PubMed ID: 19938116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients.
    Pérez-Daga JA; Ramírez-Plaza C; Suárez MA; Santoyo J; Fernández-Aguilar JL; Aranda JM; Sánchez-Pérez B; González-Sánchez A; Alvárez A; Valle M; Bondía JA
    Transplant Proc; 2008 Nov; 40(9):2959-61. PubMed ID: 19010159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
    Zekry A; Whiting P; Crawford DH; Angus PW; Jeffrey GP; Padbury RT; Gane EJ; McCaughan GW;
    Liver Transpl; 2003 Apr; 9(4):339-47. PubMed ID: 12682883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: a Scandinavian single-center experience.
    Ydreborg M; Westin J; Lagging M; Castedal M; Friman S
    Scand J Gastroenterol; 2012 Jun; 47(6):710-7. PubMed ID: 22452366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.
    Ghabril M; Dickson RC; Machicao VI; Aranda-Michel J; Keaveny A; Rosser B; Bonatti H; Krishna M; Yataco M; Satyanarayana R; Harnois D; Hewitt W; Willingham DD; Grewal H; Hughes CB; Nguyen J
    Liver Transpl; 2007 Dec; 13(12):1717-27. PubMed ID: 18044750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.